Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.885 USD | +0.17% | +3.04% | +15.40% |
09/05 | Whitefort Capital Management Engages with Arbutus Biopharma | CI |
02/05 | Transcript : Arbutus Biopharma Corporation, Q1 2024 Earnings Call, May 02, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.40% | 54Cr | |
-2.35% | 8.91TCr | |
+2.76% | 4.09TCr | |
-13.20% | 3.22TCr | |
+54.69% | 2.51TCr | |
-16.45% | 1.54TCr | |
-8.44% | 1.19TCr | |
-42.60% | 1.19TCr | |
-12.82% | 1.16TCr | |
+7.34% | 903.23Cr |
- Stock Market
- Equities
- ABUS Stock
- News Arbutus Biopharma Corporation
- Arbutus Biopharma : Wedbush Adjusts Arbutus Biopharma's Price Target to $7 From $5 Following Updated AB-729 Data, Keeps at Outperform